Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/2004
10/28/2004WO2004043386A3 Molecules preferentially associated with effector t cells and methods of their use
10/28/2004WO2004013633A3 Method for isolating atp binding proteins by means of immobolized protein inhibitors
10/28/2004WO2003087126A3 Heteroclitic analogs and related methods
10/28/2004US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004US20040214988 Preparing leucine zipper and coiled-coil proteins in which leucine residues have been replaced with 5,5,5-trifluoroleucines; site-directed mutagenesis; mimetics; improved heat/chemical resistance
10/28/2004US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214233 Protein microarray system
10/28/2004US20040214228 Selecting glycoproteins with enhanced activities for use as diagnostic tools in disease diagnosis; glycomics; proteomics
10/28/2004US20040214160 Using viruses to detect or purify proteins
10/28/2004US20040214157 Chromatographic resins and methods for using same
10/28/2004US20040213753 administrating to a skin or hair of a candidate a sponge protein hydrolysate which is a product by acidic hydrolysis of sponge skeleton fibers (spongin fibers) obtained from refined sponges as the raw material in an amount effective to stimulate cell growth of the skin or hair
10/28/2004US20040211730 Combining an organic polyol silane precursor with an additive under conditions suitable for the hydrolysis and condensation of the precursor to a siliceous material, wherein the additive is selected from the group consisting of one or more water-soluble polymers and one or more trifunctional silanes
10/28/2004CA2522205A1 Process for preparing macrocyclic compounds
10/28/2004CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004CA2521808A1 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
10/28/2004CA2521381A1 Method for preparation of site-specific protein conjugates
10/27/2004EP1471443A1 Method of constructing stereostructure of protein having plural number of chains
10/27/2004EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents
10/27/2004EP1470157A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
10/27/2004EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
10/27/2004EP1469741A1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
10/27/2004EP1418933A4 Process for preparing glycopeptide phosphonate derivatives
10/27/2004EP1141022B1 Serine protease inhibitor
10/27/2004EP1115739A4 Auxiliary for amide bond formation
10/27/2004EP1107773A4 Method for detection of legionella bacteria employing purified antigen-specific antibodies
10/27/2004CN1541335A EPF receptor assays, compounds and therapeutic compsns.
10/27/2004CN1541068A Method for prepn. of gliadin-and glutenin-rich fractions out of gluten in aqueous medium and in presence of acid
10/27/2004CN1540348A Quick magnetic method for separating and purifying thyroxin marked-by biotin
10/27/2004CN1539978A Expression vector, engineering bacteria of N* deacetylating Alpha 1 monomer of human thymosin, and preparation method
10/27/2004CN1539848A Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment
10/26/2004US6809190 Method comprising introducing one type or two or more types of a functional molecule post-synthetically following introduction of a precursor monomer unit into a peptide nucleic acid oligomer
10/26/2004US6809186 Simple method for labeled conjugate production
10/26/2004US6808934 Comprises acoustic ejection of fluid droplets from reservoirs to form arrays; for preparing combinatorial libraries for proteins
10/26/2004US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
10/26/2004US6808609 Device and method for moving charged particles
10/26/2004CA2137237C Purified forms of dnase
10/26/2004CA1341461C T helper cell growth factor
10/21/2004WO2004089974A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
10/21/2004WO2004089504A1 Regeneration of chromatographic stationary phases
10/21/2004WO2004089421A2 Methods for rational pegylation of proteins
10/21/2004WO2004089295A2 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
10/21/2004WO2004067155A3 Pre-cast electrophoresis slab gels with extended storage life
10/21/2004WO2004034971A3 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof
10/21/2004WO2004010939A3 Methods of using non-human animal apoliprotein a-i protein
10/21/2004WO2004007526A3 Method of inactivating prions
10/21/2004WO2003000014A3 Spherical protein particles and methods of making and using them
10/21/2004US20040210036 Designing amino acid sequence pools of manageable size, wherein individual peptides have the same net charge, same like net charge or neutral charge; peptide mimetic and kinase regulation
10/21/2004US20040209999 Synthesis of polypeptides by amidation of amino acids and chlorotrityl chloride linking
10/21/2004US20040209292 Mutant human hepatitis B viral strain and uses thereof
10/21/2004US20040209282 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
10/21/2004US20040209249 Using protein crystalization to identify and characterize three dimensional structure of microbial heat resistant protein; rational protein design
10/21/2004US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents
10/21/2004US20040208797 Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses
10/21/2004US20040206626 Micellar gradient focusing
10/21/2004CA2521835A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
10/21/2004CA2521438A1 Prion protein binding materials and methods of use
10/21/2004CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
10/21/2004CA2520875A1 Methods for rational pegylation of proteins
10/20/2004EP1468265A1 Systems and methods for the analysis of protein phosphorylation
10/20/2004EP1468116A2 Method for isolating nucleic acids and protein from a single sample
10/20/2004EP1468009A1 Peptide purification
10/20/2004EP1467758A2 Methods for preparing immunoconjugates
10/20/2004EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
10/20/2004CN1539014A Templated molecules and methods for using such molecules
10/20/2004CN1538973A Factor VIII separation
10/20/2004CN1537939A Method for producing recombinaton urokinase
10/20/2004CN1537938A New earthoworm plasmin and its preparation method
10/20/2004CN1537865A Method of extracting lactoalbumin, nucleic acid oligosaccharide, isoflavone, saponin from yellow waste water generated by producing soybean
10/20/2004CN1171634C Reactor and method for solid phase peptide synthesis
10/19/2004US6806360 Nucleic acids encoding human tissue factor inhibitor
10/19/2004US6806077 Method for screening substances with therapeutic action in the treatment of transmissable subacute spongiform encephalopathies
10/14/2004WO2004088323A1 Method of collecting primary structural data of protein, hydrophobic fine particulate carrier to be used therein, and system for obtaining primarty structural data of protein
10/14/2004WO2004087913A1 Process for producing modified polypeptide
10/14/2004WO2004087883A2 lovE VARIANT REGULATOR MOLECULES
10/14/2004WO2004087761A1 Purification of human monoclonal antibody and human polyclonal antibody
10/14/2004WO2004087743A2 Anti-hypertensive peptide derivatives and process for preparation thereof
10/14/2004WO2004087739A1 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
10/14/2004WO2004087308A1 Method of synthesis and testing of combinatorial libraries using microcapsules
10/14/2004WO2004087220A1 Isolation of a protein from a natural source in sterile form
10/14/2004WO2004024866A3 Protein purification
10/14/2004WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor
10/14/2004WO2003102132A3 Non-affinity purification of proteins
10/14/2004US20040204869 Method for identifying or characterizing properties of polymeric units
10/14/2004US20040204862 Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
10/14/2004US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors
10/14/2004US20040204388 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein
10/14/2004US20040203149 Composite materials comprising supported porous gels
10/14/2004US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs
10/14/2004US20040203085 Method for parallel synthesis and transfer of molecules to a substrates
10/14/2004US20040203078 Labeled complex, process for producing same and process for utilizing same
10/14/2004US20040203056 Chemical amplification for the synthesis of patterned arrays
10/14/2004US20040203049 Coresponding biopolymer information coded on magnetic strip with silicon chip linked biopolymers
10/14/2004US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004US20040202643 capable of change from insoluble and stable form to soluble and active form upon a change in temperature, pH, chemical composition, concentration, and/or change in shear force acting upon the crystal; capable of releasing their protein activity at a controlled rate
10/14/2004US20040202603 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
10/14/2004CA2520630A1 Method of synthesis and testing of combinatorial libraries using microcapsules